TG Therapeutics, Inc. TGTX
60.99 USD +1.03 (+1.73%)
Nov 3, 2026, 3:25 PM EST
60.02 Day range 62.20
26.76 52-week range 63.60
- YTD
- +104.58%
- 1 year
- +81.02%
Revenue & Expenses
Revenue by
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 616.29M | 329.00M | 233.66M | 2.79M | 6.69M | |
| 515.57M | 290.52M | 219.53M | 2.52M | 5.90M | |
| 123.32M | 41.93M | 20.63M | -218.32M | -344.77M | |
| 447.18M | 23.38M | 12.67M | -223.81M | -348.10M | |
| 2.77 | 0.15 | 0.09 | -1.65 | -2.63 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 80.49M | 181.19M | 94.22M | 103.58M | 300.15M | |
| 1.06B | 577.69M | 329.59M | 193.57M | 379.63M | |
| 415.23M | 355.33M | 169.09M | 134.99M | 142.48M | |
| 252.67M | 252.56M | 109.35M | 81.48M | 77.61M | |
| 648.02M | 222.36M | 160.50M | 58.59M | 237.15M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -24.77M | -40.52M | -31.41M | -176.17M | -295.63M | |
| 13.80M | -1.04M | -50.65M | -20.01M | -332.00K | |
| -89.73M | 128.53M | 72.70M | -391.00K | 41.42M | |
| -214.00K | -45.00K | 0 | -14.00K | -401.00K | |
| -100.70M | 86.97M | -9.36M | -196.57M | -254.55M |